Skip to main content
Clinical Trials/ISRCTN52121370
ISRCTN52121370
Completed
Not Applicable

A randomised controlled trial comparing two different immunoglobulins in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Erasmus Medical Centre (The Netherlands)0 sites25 target enrollmentJuly 16, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sponsor
Erasmus Medical Centre (The Netherlands)
Enrollment
25
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 16, 2007
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Erasmus Medical Centre (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Minimum age 18 years
  • 2\. Improvement of muscle function after start Gammagard
  • 3\. Active illness
  • 4\. Ongoing intermittent treatment with a stable Gammagard dose
  • 5\. Clinical and Electromyography (EMG) findings compatible with CIDP

Exclusion Criteria

  • 1\. Immunoglobulin A (IgA) deficiency or allergic reactions to Intravenous Immunoglobulin (IVIg)
  • 2\. Hereditary neuropathy or severe concomitant illness
  • 3\. Multifocal Motor neuropathy (MMn), atypical CIDP

Outcomes

Primary Outcomes

Not specified

Similar Trials